![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CYHR1 |
Gene summary for CYHR1 |
![]() |
Gene information | Species | Human | Gene symbol | CYHR1 | Gene ID | 50626 |
Gene name | cysteine and histidine rich 1 | |
Gene Alias | CHRP | |
Cytomap | 8q24.3 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q6ZMK1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
50626 | CYHR1 | P128T-E | Human | Esophagus | ESCC | 1.30e-38 | 1.40e+00 | 0.1241 |
50626 | CYHR1 | P130T-E | Human | Esophagus | ESCC | 2.99e-37 | 6.88e-01 | 0.1676 |
50626 | CYHR1 | S43 | Human | Liver | Cirrhotic | 5.34e-04 | -1.63e-01 | -0.0187 |
50626 | CYHR1 | HCC1_Meng | Human | Liver | HCC | 1.01e-81 | 2.41e-01 | 0.0246 |
50626 | CYHR1 | HCC2_Meng | Human | Liver | HCC | 3.40e-27 | 2.08e-01 | 0.0107 |
50626 | CYHR1 | cirrhotic1 | Human | Liver | Cirrhotic | 5.89e-03 | 1.79e-01 | 0.0202 |
50626 | CYHR1 | cirrhotic2 | Human | Liver | Cirrhotic | 5.31e-03 | 1.66e-01 | 0.0201 |
50626 | CYHR1 | cirrhotic3 | Human | Liver | Cirrhotic | 8.67e-05 | 1.53e-01 | 0.0215 |
50626 | CYHR1 | HCC2 | Human | Liver | HCC | 6.11e-07 | 2.96e+00 | 0.5341 |
50626 | CYHR1 | Pt13.b | Human | Liver | HCC | 1.20e-12 | 2.18e-01 | 0.0251 |
50626 | CYHR1 | Pt14.a | Human | Liver | HCC | 5.98e-06 | 4.18e-01 | 0.0169 |
50626 | CYHR1 | S014 | Human | Liver | HCC | 2.38e-39 | 1.72e+00 | 0.2254 |
50626 | CYHR1 | S015 | Human | Liver | HCC | 5.93e-31 | 1.96e+00 | 0.2375 |
50626 | CYHR1 | S016 | Human | Liver | HCC | 1.55e-41 | 1.72e+00 | 0.2243 |
50626 | CYHR1 | S027 | Human | Liver | HCC | 5.47e-17 | 1.61e+00 | 0.2446 |
50626 | CYHR1 | S028 | Human | Liver | HCC | 2.59e-32 | 1.74e+00 | 0.2503 |
50626 | CYHR1 | S029 | Human | Liver | HCC | 1.90e-34 | 1.85e+00 | 0.2581 |
50626 | CYHR1 | C04 | Human | Oral cavity | OSCC | 3.47e-17 | 1.08e+00 | 0.2633 |
50626 | CYHR1 | C21 | Human | Oral cavity | OSCC | 2.02e-37 | 1.02e+00 | 0.2678 |
50626 | CYHR1 | C30 | Human | Oral cavity | OSCC | 2.10e-47 | 1.66e+00 | 0.3055 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CYHR1 | SNV | Missense_Mutation | c.602N>A | p.Cys201Tyr | p.C201Y | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A8-A075-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | epirubicin | CR | ||
CYHR1 | SNV | Missense_Mutation | rs771932807 | c.1120G>A | p.Val374Met | p.V374M | protein_coding | tolerated(0.23) | benign(0.053) | TCGA-AC-A6IW-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CYHR1 | SNV | Missense_Mutation | c.1053C>G | p.Asp351Glu | p.D351E | protein_coding | tolerated(0.18) | benign(0.003) | TCGA-E2-A1LI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | ||
CYHR1 | SNV | Missense_Mutation | c.568C>T | p.Arg190Cys | p.R190C | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | ||
CYHR1 | SNV | Missense_Mutation | c.970N>G | p.Thr324Ala | p.T324A | protein_coding | tolerated(0.49) | benign(0.374) | TCGA-CK-5913-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
CYHR1 | SNV | Missense_Mutation | c.431N>A | p.Arg144Gln | p.R144Q | protein_coding | deleterious(0.04) | possibly_damaging(0.614) | TCGA-CM-6675-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | fluorouracil | PD | ||
CYHR1 | SNV | Missense_Mutation | c.1081N>G | p.His361Asp | p.H361D | protein_coding | tolerated(0.17) | benign(0.031) | TCGA-D5-5538-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | calcium | PD | ||
CYHR1 | SNV | Missense_Mutation | c.634N>T | p.Arg212Cys | p.R212C | protein_coding | tolerated(0.08) | possibly_damaging(0.679) | TCGA-DM-A1HB-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | ||
CYHR1 | SNV | Missense_Mutation | novel | c.881N>T | p.Thr294Met | p.T294M | protein_coding | deleterious(0) | probably_damaging(0.927) | TCGA-D1-A16F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
CYHR1 | SNV | Missense_Mutation | novel | c.643T>C | p.Cys215Arg | p.C215R | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |